Emotional, hyperactivity and inattention problems in adolescents with immunocompromising chronic diseases during the COVID-19 pandemic

Imagem de Miniatura
Arquivos
art_CAMPOS_Emotional_hyperactivity_and_inattention_problems_in_adolescents_with_2023.PDF (387.46 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Autores
Citação
CLINICS, v.78, article ID 100167, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To assess factors associated with emotional changes and Hyperactivity/Inattention (HI) motivated by COVID-19 quarantine in adolescents with immunocompromising diseases.Methods: A cross-sectional study included 343 adolescents with immunocompromising diseases and 108 healthy adolescents. Online questionnaires were answered including socio-demographic data and self-rated healthcare routine during COVID-19 quarantine and validated surveys: Strengths and Difficulties Questionnaire (SDQ), Pitts-burgh Sleep Quality Index (PSQI), Pediatric Quality of Life Inventory 4.0 (PedsQL4.0).Results: The frequencies of abnormal emotional SDQ scores from adolescents with chronic diseases were similar to those of healthy subjects (110/343 [32%] vs. 38/108 [35%], p = 0.548), as well as abnormal hyperactivity/inat-tention SDQ scores (79/343 [23%] vs. 29/108 [27%], p = 0.417). Logistic regression analysis of independent var-iables associated with abnormal emotional scores from adolescents with chronic diseases showed: female sex (Odds Ratio [OR = 3.76]; 95% Confidence Interval (95% CI) 2.00-7.05; p < 0.001), poor sleep quality (OR = 2.05; 95% CI 1.08-3.88; p = 0.028) and intrafamilial violence during pandemic (OR = 2.17; 95% CI 1.12-4.19; p = 0.021) as independently associated with abnormal emotional scores, whereas total PedsQL score was inversely associated with abnormal emotional scores (OR = 0.95; 95% CI 0.93-0.96; p < 0.0001). Logistic regression analysis associated with abnormal HI scores from patients evidenced that total PedsQL score (OR = 0.97; 95% CI 0.95-0.99; p = 0.010], changes in medical appointments during the pandemic (OR = 0.39; 95% CI 0.19-0.79; p = 0.021), and reliable COVID-19 information (OR = 0.35; 95% CI 0.16-0.77; p = 0.026) remained inversely associated with abnormal HI scores.Conclusion: The present study showed emotional and HI disturbances in adolescents with chronic immunosuppres-sive diseases during the COVID-19 pandemic. It reinforces the need to promptly implement a longitudinal pro-gram to protect the mental health of adolescents with and without chronic illnesses during future pandemics.
Palavras-chave
COVID-19, Mental health, Adolescent, Chronic disease
URI
https://observatorio.fm.usp.br/handle/OPI/53789
Referências
  1. Angelina S, 2021, CLIN EPIDEMIOL GLOB, V12, DOI 10.1016/j.cegh.2021.100903
  2. Astley C, 2021, PEDIATR RHEUMATOL, V19, DOI 10.1186/s12969-021-00646-7
  3. Bilginer Cilem, 2021, Minerva Pediatr (Torino), DOI 10.23736/S2724-5276.21.06178-4
  4. EHCAP, 2014, SCOR STRENGTHS DIFF
  5. Ezpeleta L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197327
  6. Fegert JM, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00329-3
  7. Fleitlich B. W., 2000, INFANTO REV NEUROPSI, V1, P44
  8. Helito AC, 2021, CLINICS, V76, P3501
  9. Irfan O, 2021, ARCH DIS CHILD, V106, P440, DOI 10.1136/archdischild-2020-321385
  10. Jones EAK, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052470
  11. Kang CY, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102081
  12. Klatchoian DA, 2008, J PEDIAT-BRAZIL, V84, P308, DOI [10.1590/S0021-75572008000400005, 10.2223/JPED.1788]
  13. Kovess-Masfety V, 2016, SOC PSYCH PSYCH EPID, V51, P1093, DOI 10.1007/s00127-016-1253-0
  14. Lavorato SSM, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e2688
  15. Lindoso L, 2022, J PEDIAT-BRAZIL, V98, P350, DOI 10.1016/j.jped.2021.09.002
  16. Magson NR, 2021, J YOUTH ADOLESCENCE, V50, P44, DOI 10.1007/s10964-020-01332-9
  17. Marques IG, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e2655
  18. Mazzolani BC, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.714120
  19. Nobari H, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094563
  20. Safadi MAP, 2021, REV PAUL PEDIATR, V39, DOI 10.1590/1984-0462/2020/38/2020192
  21. Panda PK, 2021, J TROP PEDIATRICS, V67, DOI 10.1093/tropej/fmaa122
  22. Pandey K, 2021, BRAIN RES BULL, V176, P161, DOI 10.1016/j.brainresbull.2021.08.012
  23. Passos MHP, 2017, J PEDIAT-BRAZIL, V93, P200, DOI 10.1016/j.jped.2016.06.006
  24. Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381
  25. Ravens-Sieberer U, 2022, EUR CHILD ADOLES PSY, V31, P879, DOI 10.1007/s00787-021-01726-5
  26. Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98
  27. Samji H, 2022, CHILD ADOL MENT H-UK, V27, P173, DOI 10.1111/camh.12501
  28. Serlachius A, 2020, JMIR PEDIATR PARENT, V3, DOI 10.2196/23057
  29. Silva CA, 2020, CLINICS, V75, P1931
  30. Singh S, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113429
  31. Siste K, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.665675
  32. Sousa BLA, 2022, REV PAUL PEDIATR, V40
  33. Takeshima M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91050-4
  34. Tso WWY, 2022, EUR CHILD ADOLES PSY, V31, P161, DOI 10.1007/s00787-020-01680-8
  35. Vilella A, 2021, CURR ALLERGY ASTHM R, V21, DOI 10.1007/s11882-021-01007-w
  36. Washington DC, 2021, MIT DIR IND CONS COV
  37. Williams N, 2021, EUR J PEDIATR, V180, P689, DOI 10.1007/s00431-020-03801-6
  38. Zuccolo PF, 2023, EUR CHILD ADOLES PSY, V32, P1083, DOI 10.1007/s00787-022-02006-6

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Carregar mais